Nvidia, AMD Could See Billions in Revenue from Soaring China AI Demand in 2026
This article first appeared on GuruFocus. Shares of Nvidia (NASDAQ:NVDA) and AMD (NASDAQ:AMD) inched up about 0.5% on…
2 Artificial Intelligence Stocks That Will Be Worth More Than Nvidia by the End of 2026
Nvidia stock is at risk in 2026 if revenue growth slows down. Alphabet is gaining market share back…
Which AI Orchestration Stock Will Outperform in 2026?
Palantir has been one of the best growth stories in the market. UiPath is just beginning to see…
Is Palantir the Top Artificial Intelligence Stock for 2026?
Palantir Technologies (NASDAQ: PLTR) has been an exceptional stock pick over the past three years. In 2023, the…
Should You Buy Artificial Intelligence (AI) Stocks In 2026?
Stocks like Nvidia and Microsoft have struggled in the last few months, bringing their valuations down with them.…
How Recent AI Moves Are Changing the Story Behind Microsoft’s Valuation
Microsoft stock’s narrative is shifting at the margins, with the fair value estimate edging down slightly from about…
2 Best AI Stocks to Buy in December
AI stocks have taken a beating since Oracle and Broadcom released their earnings results, and these two look…
Should NVIDIA’s US$2 Billion AI Partnership And Synopsys’ Strong Q4 Results Require Action From Synopsys (SNPS) Investors?
In December 2025, Synopsys reported fourth-quarter revenue of US$2,254.86 million and basic EPS from continuing operations of US$2.42,…
Nebius Group vs. Iren Limited
Companies appear set to spend trillions on AI infrastructure this decade. Nebius Group is growing fast, but its…
This Artificial Intelligence Stock Could Be a Top Performer in the Next Market Rally
CoreWeave stands out in the marketplace with AI-specific cloud servers. Revenue growth is in the triple digits. Heavy…
Is SoundHound AI Stock a Buy?
SoundHound AI’s stock has dropped more than 50% from its all-time high. It disappointed its early investors by…
Lilly’s GLP-1 Surge Dwarfs Abbott’s Steady Device Growth With 54% Revenue Jump
24/7 Wall St. Abbott Laboratories (ABT) grew revenue 6.9% with medical devices up 14.8% to $5.45B. Abbott reaffirmed…